AZD-2423

N/A

Report date: 2022/07/19 20:00:45

Base Information

Drug NameAZD-2423
Drug Alias NameAZD-2423
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-C chemokine receptor type 2 antagonists
TargetsC-C chemokine receptor type 2
Therapy Area/IndicationsNeuralgiaPulmonary Disease, Chronic ObstructiveLung Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBulgariaCanadaUnited States +[12] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstrazeneca Plc
Active IndicationsN/A
Inactive IndicationsNeuralgiaPulmonary Disease, Chronic ObstructiveLung Diseases

Other Information

ATC CodeN/A
Related LinksN/A